Replication of live attenuated cold-adapted H2N2 influenza virus vaccine candidates in non human primates

The development of an H2N2 vaccine is a priority in pandemic preparedness planning. We previously showed that a single dose of a cold-adapted (ca) H2N2 live attenuated influenza vaccine (LAIV) based on the influenza A/Ann Arbor/6/60 (AA ca) virus was immunogenic and efficacious in mice and ferrets....

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Vaccine
Autori principali: Broadbent, Andrew J., Santos, Celia P., Paskel, Myeisha, Matsuoka, Yumiko, Lu, Janine, Chen, Zhongying, Jin, Hong, Subbarao, Kanta
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2014
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4259263/
https://ncbi.nlm.nih.gov/pubmed/25444799
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2014.10.065
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi